Innate immunity in diabetes and diabetic nephropathy
Jun Wada(Okayama University), Hirofumi Makino(Okayama University Hospital)
Cited by 424
Related Papers
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|609
The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis
|Arthritis Research & Therapy|2006|321
Simvastatin antagonizes tumor necrosis factor-α inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway
|Journal of Endocrinology|2008|118
Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis
|Scientific Reports|2015|87